Ibex Medical Analytics Announces Expansion of its Biopharma Business, Extending AI Pathology Platform into Early Biomarker Development [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Building on its successful collaborations in late-stage biomarker development , Ibex is now extending its platform into earlier translational research, biomarker development, and trial-efficiency optimization. Ibex's high-performance AI platform—already deployed across more than 50 health systems worldwide and used in collaboration with major industry organizations such as Philips and Roche —now supports exploratory, preclinical, and clinical evidence generation, while providing a seamless foundation for future companion diagnostic (CDx) programs. "In an era where modalities like antibody-drug conjugates (ADC), immune-modulating agents, and molecularly guided therapies are reshaping oncology, the field needs biomarkers that match the complexity of our treatments and enable adequate patient selection", says Paolo Tarantino, M.D., Research and Clinical Fellow at Dana-Farber Cancer Institute and Harvard Medical School. "AI-based biomarker platforms can integrate multiple dimensions o
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche [Yahoo! Finance]Yahoo! Finance
- A Look At Roche Holding's (SWX:ROG) Valuation As TIGIT And AI Pathology Progress Draw Fresh Attention [Yahoo! Finance]Yahoo! Finance
- Roche (OTCMKTS:RHHBY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG) [Yahoo! Finance]Yahoo! Finance